Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Boring...
Boring and repetitive idiot.
Yawn.. beyond boring.
Aim is terrible. When on the release of good news, the initial rise disappears and the share price ends up down on the day. Then there never seems to be the volume to take the price back up. It deters any long term investing from those that are new to the aim market.
Ps! I think that hemo will go back up later due to news still due and the posible value of a clinical product. And for the brave the mms are giving the opportunity to buy at prices that ignore the news so far.
The mm makers dropping the price to encourage buying as soon as volume dies down us probrably the reason that most shares are radically undervalued. The mm system is here for them only. It needs changing. Lots of companies have been bought out by the americans.
500k at 215. Sell? Dont be so bl..dy stupid.
Nice 500k buy after the close. 2.115 pence. It bodes well for tomorow.
I wonder if anyone reads the stupid ones. If they do they have to pay more for a share that is about to issue major news. Sometimes the tick ups on the end of the graphs are a nice sign.
2.10 v 2.20.
One trick pony ? Nope, there are other parts of the business mentioned in the funding. These can release lesser news, but highlight importance.
467 trade at around 2.13. Very small trades are allways priced higher. But this might turn out to be an indicator for the rest of the day.
Spread. Opened 2.05 v 2.10. Now 2.05 v 2.20. Last trade was around 2.095? It is either a lack of sellers or back ground buying. The two combined perhaps. Wither way the tide may have turned.
A 400k buy just gone through. Not huge but there is interest does seem to be building.
As I say ..its better to read the updates. They are not full of totally useless garbage opinions.
How close is the near future. Allot closer after the last two rns statements. Clinical has moved allot closer and the share price has not really moved far above its low point. It looks a good one to accumulate.
Once again there are allot of idiots on here. Time to read the rns statements and understand the current situation.
Zero is preferable
Less is more. And preferred by most.
The main thing is the buying interest. Nice and steady at the moment. And I do not think that 2.10 is a round number. Investors are buying ahead of any clinical news.
Thule black sands... upgrade due soon.
I read that one. It's one of your better posts. Its normally war and peace loaded with excrement.